{
  "attach_pages": "5",
  "attach_size": "598",
  "attach_type": "0",
  "attach_url": "https://pdf.dfcfw.com/pdf/H3_AP201703230430478186_1.pdf?1559743204000.pdf",
  "company_code": "80000134",
  "eitime": "2017-03-23 13:49:20",
  "extend": {},
  "info_code": "AP201703230430478186",
  "language": "0",
  "notice_date": "2017-03-23 00:00:00",
  "notice_title": "业绩实现稳健增长，长期受益两票制和处方外流",
  "page_size": 1,
  "page_size_ch": 0,
  "page_size_cht": 0,
  "page_size_en": 0,
  "publish_relation": {
    "originalCode": "465",
    "publishName": "化学制药"
  },
  "rating": "BBB",
  "researcher": "徐曼",
  "security": [
    {
      "market_uni": "1",
      "publish_relation": [
        {
          "originalCode": "1042",
          "publishName": "医药商业"
        }
      ],
      "short_name": "上海医药",
      "short_name_ch": "上海医药",
      "short_name_cht": "上海醫藥",
      "short_name_en": "SHANGHAI PHARMA",
      "stock": "601607"
    }
  ],
  "short_name": "上海医药",
  "source_sample_name": "华金证券",
  "star": "1"
}